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In blood cells RUNX1 directly stimulates G1 to S cell-cycle pro-
gression and regulates speciﬁc genes and cytokine receptors. In
addition, genetic variation in the RUNX1 gene has been implicated
in susceptibility to rheumatoid arthritis in Japanese populations.
We hypothesized that variation in the RUNX1 gene could be
involved in genetic susceptibility to osteoarthritis.
Methods: 1983 knee OA cases (1232 total knee replacement pa-
tients and 751 with radiographic disease only), 1283 hip OA cases
(1119 total hip replacement patients and 149 with radiographic
disease only) and 2317 controls from the UK were genotyped
for three tagging single nucleotide polymorphisms (SNPs) in the
RUNX1 gene and genetic association was tested.
Results: Differences in allele frequencies did not achieve sta-
tistical signiﬁcance between hip OA and controls (p<0.065) nor
between knee OA and controls (p< 0.370). Nevertheless, we found
that the rare homozygotes at both rs2834656 and rs2834662 were
signiﬁcantly associated with lower risk of hip OA OR=0.63 (95% CI
0.46-0.88) p<0.006 and OR=0.70 (95% CI 0.51-0.94) p<0.019 re-
spectively. No such association was seen with knee OA (OR=0.88,
95% CI 0.67- 1.15 and p=0.358)
Conclusions:Our data indicate that polymorphisms in the RUNX1
gene may be involved in genetic susceptibility of hip OA but not
knee OA.This work was supported by the Arthritis and Research
Campaign and by the European Union FP7 large collaborative
project grant 200800 TREAT-OA
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Purpose: Gene activity can be regulated or silenced by epi-
genetic control mechanisms, for example methylation. An EN-
CODE dataset of genome wide transcriptional repressor CCCTC-
binding factor (CTCF) binding shows a CTCF binding peak in the
proximity of rs225014, an OA susceptibility SNP within the DIO2
gene. In this study we set off to explore differences in methylation
status of DIO2 between blood and cartilage DNA as well as in
healthy and OA cartilage.
Methods: We collected cartilage material from subjects under-
going total joint arthroplasty and whole blood from OA patients.
Cartilage was snap frozen in liquid nitrogen and stored at -80°C.
Cartilage was ground up in a Retsch MM200 sample disintegrator
and RNA and DNA were extracted using Qiagen columns. Blood
DNA was collected by use of a Qiagen column. DNA was bisulﬁte
treated using the Zymo Research EZ DNA methylation bisulﬁte
kit and 13 DIO2 CpG sites were PCR ampliﬁed and quantitatively
assessed for DNA methylation using a mass spectrometry based
method (Epityper, Sequenom).
Results: The DNA methylation levels in cartilage (N=3) and blood
(N=7) could be analyzed for 12 out of 13 DIO2 CpG dinucleotides.
Overall, our preliminary data show that blood DNA performed
better upon bisulﬁte treatment as compared to cartilage DNA,
giving more robust data for blood. However, overall the methylation
status of the DIO2 in cartilage appeared higher as compared to
blood. For blood the average DIO2 methylation was 0.67, with
methylation status per CpG dinucleotide ranging from an average
of 0.1 to 0.96 (mean standard deviation 0.23 ranging from 0.04 to
0.17).
Conclusions: These preliminary data indicate that CpG methy-
lation within the DIO2 gene varies between individuals and that
we can consistently measure this variation. The overall hyper-
methylation of DIO2 in healthy cartilage as compared to blood
might be indicative of epigenetic control of the DIO2 within dif-
ferent tissues. This should be substantiated through the ongoing
collection of DNA from both healthy and OA affected cartilage,
which may also provide insights in possible differential methylation
of DIO2 in OA. Unraveling epigenetic regulation at developmental
genes within cartilage may elucidate additional mechanisms of the
complex etiology of OA.
374
ASSOCIATION OF LEPTIN GENE (LEP) WITH BODY MASS
INDEX (BMI) IN HAN CHINESE
J. Qin
Drum Tower Hosp. Afﬁliated to, NanJing, China
Purpose: Although the number of candidate genes has increased
and several polymorphisms have been studied in human popu-
lations, knowledge about genetic factors underlying the suscep-
tibility to obesity remains incomplete. This study assessed the
contribution of leptin gene polymorphism to BMI in Chinese Han
population.
Methods: 3 tag SNPs of LEP were selected by haploviewer
software from Hapmap database. They cover all the SNPs of
LEP whose heterozygosis rate are over 10%. We genotyped the
selected SNPs in 615 individuals ≥40 years old live in and around
Nanjing, China, compared allelic and genotypic frequencies and
haplotype distribution between normal range (BMI = 18.50-24.99)
and overweight (BMI ≥ 25.00) groups.
Results: Associations were observed in haplotype CAT (P=0.009)
and AGC (P=0.005) between the two groups, with the sequence
of loci chosen for hap-analysis is rs11761556, rs12706832,
rs2071045. No association between the genotypes and allele
frequences was observed between the two groups.
Conclusions: These ﬁndings suggest there is an association be-
tween LEP and BMI and it’s a ﬁrst report examined the relationship
between LEP polymorphisms and BMI in Han Chinese.
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LARGE-SCALE ASSOCIATION STUDY OF SUSCEPTIBILITY
GENES FOR LUMBAR DISC HERNIATION
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CGM, RIKEN, Tokyo, Japan
Purpose: Lumbar disc herniation (LDH) is a common disease,
a predominant cause of low back pain and unilateral leg pain.
Although many risk factors have been reported for LDH, its etiol-
ogy and pathogenesis are for the most part unknown. The strong
familial predisposition for LDH and lumbar disc degeneration has
been established through a number of family and twin studies.
Recently, several susceptibility genes have been reported to asso-
ciate with LDH and related conditions. Most encode extracellular
matrix (ECM) proteins in the intervertebral disc, suggesting the
importance of ECM metabolism in LDH. The aim of the study is
to examine susceptibility genes for LDH through a candidate gene
approach for the cartilage genes.
Methods: Subjects.
Case-control association analyses were performed for LDH can-
didate genes by a two-step screening. We recruited a total of
nearly 1,000 cases and 1,000 controls for the ﬁrst screen and
the replication study. Affected individuals with LDH were recruited
from 19 collaborating hospitals. The diagnosis of LDH required the
following three criteria: 1) diagnosis of LDH by MRI; 2) treatment
and monitoring for >1 year by orthopedic surgeons; and 3) a
history of unilateral pain radiating from the back along the femoral
or sciatic nerve to the corresponding dermatome of the nerve
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root for >3 months. We extracted genomic DNA from peripheral
blood leukocytes of affected individuals and controls using stan-
dard protocols. Written informed consent was obtained from each
subject.
Genotyping and Statistical Analysis.
We genotyped SNPs using the multiplex PCR-based Invader as-
say, TaqMan SNP genotyping assays, or by direct sequencing
of PCR products. We assessed association and Hardy-Weinberg
equilibrium using the χ2 test. We estimated haplotype frequencies
using the expectation-maximization algorithm.
Functional Studies.
Allelic difference in the function of the associated SNPs was
examined in vitro and in vivo according to their possible roles in
pathogenesis of LDH and available experimental resources.
Results: We selected candidate genes based on our prior
knowledge on their function, expression, animal models, and
human monogenic diseases, etc. CILP (cartilage intermediate
layer protein), ASPN (asporin), COL11A1, THBS2 (thrombospon-
dine 2), MMP9 (matrix metaloprotease 9) and SKT (sickle tail)
were found to be associated with LDH. CILP-susceptibility allele
was a missense SNP whose predicted protein product had a
stronger inhibitory effect on TGF-β function for cartilage differenti-
ation. COL11A1-susceptibility allele showed decreased COL11A1
mRNA expression in vitro and in vivo. ASPN and SKT associations
were replicated in different ethnic groups. THBS2 -susceptibility al-
lele was located in a polypyrimidine tract upstream of the 3’-splice
site an intron 10 and exerted allelic differences on exon skipping
rates in vivo, with the susceptibility allele showing increased skip-
ping. The exon skipping resulted in decreased THBS2 interaction
with MMP2 and MMP9.
Conclusions: Through a large-scale candidate gene approach,
we have found several LDH-susceptibility genes, which would help
in clarifying the pathogenesis of LDH and in developing innovative
treatment for LDH.
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ASSOCIATION BETWEEN IL-4 RECEPTOR α AND TGF-β1
POLYMORPHISMS AND HAND OA
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Purpose: Osteoarthritis (OA) is a common disease characterised
by the degeneration of the cartilage of synovial joints such as
the hip and knee. Available evidence suggests that genetic fac-
tors play a major role in etiology of OA. The gene product of
IL-4 receptor (IL-4R) regulates cartilage chondrocyte differentia-
tion and survival. Transforming growth factor (TGF)-beta, on the
other hand, regulates the function of ﬁbroblasts, and has been
shown to have a role in the pathogenesis of rheumatoid arthritis.
These enzymes may therefore play an important role in devel-
opment of OA. Both IL-4R and TGF genes have been shown to
exhibit genetic polymorphisms with functional consequences. We
examined whether these gene polymorphisms modiﬁed individual
susceptibility to hand OA in Finnish women.
Methods: Radiographs of both hands of 543 Finnish women aged
45-63 years were examined and classiﬁed for the presence of OA
using reference images. Hand OA was deﬁned by the presence
of radiographic ﬁndings of grade 2 or more in least two joint pairs
(symmetrical OA) or in least two DIP joint pairs (symmetrical DIP
OA). The IL-4R Ser503Pro (rs1805015) and TGFB1 Leu10Pro
(rs1982073) genotypes were determined using TaqMan-based
methods. Data regarding anthropometric measures and other risk
factors were collected by questionnaire.
Results: No signiﬁcant association was found between the IL-4R
Ser503Pro polymorphism and hand OA. However, the TGF-β1
10Pro allele posed a 1.6-fold (95% CI 1.0-2.5) and a 1.8-fold
(95% CI 1.0-2.6) risk of symmetrical OA and symmetrical DIP OA,
respectively. Moreover, the risk of symmetrical OA was almost 6-
fold (OR 5.6, 95% CI 1.3-24.7) among carriers of the combination
of IL-4R 503Pro and TGF-β1 10Leu alleles.
Conclusions: Our results suggest that the studied IL-4R- and
TGF-β1-gene polymorphisms may play a role in the etiology of
polyarticular hand OA.
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FUNCTIONAL ANALYSIS OF THE GROWTH AND
DIFFERENTIATION FACTOR 5 REGULATORY
POLYMORPHISM THAT IS ASSOCIATED WITH
OSTEOARTHRITIS SUSCEPTIBILITY
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Purpose: Over the past decade, a genetic component for the
multifactorial disease osteoarthritis (OA) has been established.
Among others, a consistent and reproducible association with OA
was found for the single nucleotide polymorphism (SNP) rs143383
(T/C) in the 5’UTR of the growth and differentiation factor 5 (GDF5)
gene with a lower expression of the risk-associated T-allele in vitro
and in vivo, the latter in cartilage tissue from OA patients. To further
characterize its role in OA susceptibility, we have expanded the
analyses of the effect of this SNP on GDF5 allelic expression to
more joint tissues, and searched for cis and trans factors that
interact with the SNP.
Methods: Tissues (cartilage, fat pad, meniscus, synovium, liga-
ments) were collected from OA patients undergoing joint replace-
ment of the hip or knee. Nucleic acid was extracted and, using
rs143383 and an assay that discriminates and quantiﬁes allelic ex-
pression, the relative amount of GDF5 expression from the T and
C alleles was measured. Electrophoretic mobility shift (EMSA) and
luciferase assays were used to search for trans factors regulating
transcriptional expression of GDF5 at rs143383.
Results: We observed a consistent allelic expression imbalance
of GDF5 with a reduced expression of the risk-associated T-allele
of approximately 20% in all tissues tested, implying that the func-
tional effect rs143383 mediates on GDF5 expression is joint-wide.
A differential binding of transcription factor(s) to rs143383 was
revealed by EMSA. Among putative candidates tested, DEAF1
showed preferential binding to the T-allele of rs143383. Testing
GDF5 promoter constructs in a luciferase assay conﬁrmed DEAF1
as being involved in the transcriptional regulation of GDF5 with a
stronger repression of the T-allele at rs143383. However, we iden-
tiﬁed a further polymorphism in the 5’UTR of GDF5 (rs143384),
which strongly inﬂuenced transcriptional regulation and allelic ex-
pression at rs143383.
Conclusions: The OA susceptibility being mediated by polymor-
phism in GDF5 is not restricted to cartilage, emphasising the need
to consider the disease as involving the whole joint. DEAF1 is
a trans-acting factor that merits further investigation as a tool for
potentially modulating GDF5 expression, and the existence of an
additional cis-acting regulatory polymorphism highlights the com-
plexity involved in regulating the expression of this important OA
susceptibility locus.
